Presentation Information
[S-36-1]Strategies to overcome ALS based on the Japanese ALS registry (JaCALS)
Naoki Atsuta1, Ryoichi Nakamura1, Genki Tohnai2, Gen Sobue3 (1.Department of Neurology, Aichi Medical University School of Medicine, Japan, 2.Division of ALS Research, Aichi Medical University School of Medicine, Japan, 3.Aichi Medical University, Japan)
Naoki Atsuta graduated from Nagoya University School of Medicine in 1996. After completing his clinical training, he became a neurologist and earned his degree from Nagoya University Graduate School of Medicine. He served as the ward chief of Neurology at Nagoya University Hospital from 2009 to 2020. Since November 2020, he has been working as an Associate Professor at Aichi Medical University.
Since 2005, he has been a central contributor to the establishment, operation, and analysis of JaCALS, a registry of ALS patients in Japan. He has also participated as a site principal investigator (PI) in many ALS clinical trials, including those for edaravone and methylcobalamin. Additionally, he is a member of the ALS Clinical Guidelines Committee of the Japanese Society of Neurology and is also a member of the committee working on the clinical evaluation guidelines for ALS clinical trials.
Since 2005, he has been a central contributor to the establishment, operation, and analysis of JaCALS, a registry of ALS patients in Japan. He has also participated as a site principal investigator (PI) in many ALS clinical trials, including those for edaravone and methylcobalamin. Additionally, he is a member of the ALS Clinical Guidelines Committee of the Japanese Society of Neurology and is also a member of the committee working on the clinical evaluation guidelines for ALS clinical trials.